๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chandigarh
Clinical trial register · India

Clinical Trials in Chandigarh, 2026

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1132 matching records held by the registry are in this view. Synced 27 Sep 2026, 03:16 UTC
1132
Studies in scope
all four open statuses
613
Recruiting now
open to new participants
221
Lead sponsors
across recruiting studies
Top sites
New Delhi 335 Mumbai 261 Hyderabad 238 Bangalore 199 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh28 Novartis Pharmaceuticals5 Sanofi5 All India Institute of Medical Sciences4 Boehringer Ingelheim4
Site location
New Delhi335 Mumbai261 Hyderabad238 Bangalore199 Pune189
All 275 locations
Target enrolment
to

Trials with a site in Chandigarh

104 of 1132 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial
NCT07075315Acute-On-Chronic Liver Failure
Institute of Liver and Biliary Sciences, India
Phase 3
100
Chandigarh, New Delhi
2028-01
Not yet open
A Study of Itraconazole and Posaconazole for Chronic Pulmonary Aspergillosis
NCT07825259Chronic Pulmonary Aspergillosis
DrugsPosaconazole·Itraconazole
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3
220
Chandigarh
2026-11-01
Not yet open
Efficacy of Diloxanide Furoate as Additional Luminal Agent Along With Metronidazole for the Treatment of Amoebic Liver Abscess
NCT07807150Liver Abscess, Amoebic Liver Abscess
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3
220
Chandigarh
2026-09-04
Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT07422480Myelodysplastic Syndrome, Anemia
DrugsEpoetin Alfa·Elritercept
Takeda
Phase 3
300
Kochi, Pune, Vellore, Hyderabad, Chandigarh, Delhi
2026-05-21
Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
NCT06948214Growth Hormone Deficiency (GHD)
DrugLUM-201
Lumos Pharma
Phase 3
150
Mumbai, Nashik, Jaipur, Madurai, Chandigarh
2026-05-20
Recruiting
Microplastics, Cirrhosis and Portal Hypertension
NCT07280390Cirrhosis, Microplastics, Portal Hypertension Related to Cirrhosis, Nanoplastics
Post Graduate Institute of Medical Education and Research, Chandigarh
Observational
30
Chandigarh
2026-05-01
Recruiting
Comparison of FDG-PET/CT and CECT-CAP as Upfront Imaging Modality for the Diagnosis of Pyrexia of Unknown Origin
NCT07816783Pyrexia
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
132
Chandigarh
2026-04-09
Recruiting
DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
NCT07322237Cirrhotic Cardiomyopathy, Empagliflozin, Cardiometabolic Risk Factors, Cirrhosis
DrugsCarvedilol·Dapagliflozin
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
400
Chandigarh
2026-04-01
Recruiting
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
NCT07027306Osteoporotic Fractures, Osteoporosis
AO Foundation, AO Spine
Observational
648
Chandigarh
2026-03-19
Recruiting
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
NCT05570422Cervical Cancer
DrugsKortuc·Cisplatin
Kortuc, Inc.
Phase 1
70
Chandigarh
2026-03-01
Recruiting
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302Acute Ischemic Stroke
DrugTenecteplase
Boehringer Ingelheim
Phase 3
1,325
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Bikaner, Calicut, Chandigarh, Coimbatore
2026-02-17
Not yet open
Affordable Made-in-India Microspheres for Liver Cancer Therapy
NCT07436988Hepatecellular Carcinoma
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 1
18
Chandigarh, Mumbai, Bhubaneswar, Puducherry, Delhi
2026-02-15
Recruiting
Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis
NCT07286643Cirrhosis, Liver, Cirrhotic Cardiomyopathy, Septic Shock
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
140
Chandigarh
2026-01-01
Recruiting
Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)
NCT07245264Chronic Subdural Hematoma
DrugTranexamic Acid
St. Olavs Hospital
Phase 2/3
274
Chandigarh
2025-12-10
Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
NCT07225504Secondary Progressive Multiple Sclerosis (SPMS)
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 3
1,275
Gurugram, Mangalore, Kochi, New Delhi, Chandigarh, Vellore, Hyderabad
2025-11-11
Recruiting
Home-based Pulmonary Rehabilitation in Interstitial Lung Disease
NCT07830602Interstitial Lung Diseases
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
80
Chandigarh
2025-11-01
Not yet open
Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients
NCT04480619Angiogenic Breast Cancer
Advanced Imaging Projects, LLC
Phase 1/2
25
Chandigarh, New Delhi
2025-10-30
Recruiting
Nasojejunal Feeding Versus Oral Feeding Following Endoscopic Drainage of Walled Off Pancreatic Necrosis
NCT07395778Walled Off Pancreatic Necrosis, Acute Pancreatitis (AP), Endoscopic Ultrasound-Guided Drainage
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
50
Chandigarh
2025-10-18
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
NCT07165028Metabolic Dysfunction-Associated Steatotic Liver Disease
DrugsRetatrutide·Tirzepatide
Eli Lilly and Company
Phase 3
4,500
Ahmedabad, Bhubaneswar, Chandigarh, Ernฤkulam, Hyderabad, Jaipur, Kochi, Kolkata
2025-10-15
Recruiting
Safety and Efficacy of Dexmedetomidate vs. Midazolam for Procedural Sedation During Medical Thoracoscopy
NCT07184801Medical Thoracoscopy
DrugsMidazolam·Dexmedetomidine
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3
56
Chandigarh
2025-10-01
Recruiting
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
NCT07202884Urinary Incontinence,Stress
DrugOrforglipron
Eli Lilly and Company
Phase 3
1,000
Ahmedabad, Belagavi, Belgavi, Bhubaneswar, Chandigarh, Chennai, Hyderabad, Nagpur
2025-09-30
Recruiting
A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
NCT07141004Arthritis, Psoriatic
DrugGuselkumab
Johnson & Johnson Private Limited
Phase 4
100
Ahmedabad, Chandigarh, Chennai, Gorakhpur, Hyderabad, Mumbai, New Delhi, Patna
2025-08-12
Recruiting
Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)
NCT07072624Seizures, Traumatic Brain Injuries, Traumatic Brain Injury (TBI) Patients
DrugsPhenytoin·Levetiracetam
All India Institute of Medical Sciences, Jodhpur
Phase 4
1,260
Chandigarh, Jodhpur, Lucknow
2025-07-23
Recruiting
A Study on Bedside Formate Assay as a Diagnostic Tool in Methanol Poisoning
NCT06881641Metabolic Acidosis
University of Edinburgh
Observational
6,120
Chandigarh
2025-06-22
Recruiting
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
NCT06431919Decompensated Cirrhosis, Cirrhotic Cardiomyopathy, Cirrhosis, Liver, Left Ventricular Diastolic Dysfunction
DrugsSimvastatin·Carvedilol
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
260
Chandigarh
2025-06-10
Recruiting
Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser
NCT06996353Refractive Errors
London Vision Clinic
Observational
150
Chandigarh, Chennai
2025-05-26
Active, closed
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
NCT07030517Multiple Myeloma
DrugTeclistamab
Johnson & Johnson Private Limited
Phase 4
75
Bangalore, Bengaluru, Chandigarh, Jaipur, Kolkata, Mumbai, Nagpur, New Delhi
2025-05-22
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
NCT06962800Primary Membranous Nephropathy
DrugsFelzartamab·Tacrolimus
Biogen
Phase 3
180
Hyderabad, Bangalore, Pune, New Delhi, Lucknow, Varanasi, Kolkata, Chandigarh
2025-05-22
Recruiting
Efficacy of Pregabalin for Diabetic Pruritus - A Randomized Controlled Study.
NCT06790537Diabetic Pruritus, Efficacy of Pregabalin in Controlling Diabetic Pruritus Severity
DrugPregabalin
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
46
Chandigarh
2025-04-17
Recruiting
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies
NCT06906445Ulcerative Colitis
All India Institute of Medical Sciences
Not applicable
220
Kochi, Mumbai, New Delhi, Ludhiana, Chandigarh, Varanasi
2025-03-15
Recruiting
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis
NCT06895252Ulcerative Colitis (UC)
All India Institute of Medical Sciences
Not applicable
220
Kochi, Mumbai, New Delhi, Ludhiana, Chandigarh, Varanasi
2025-03-15
Recruiting
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease
NCT06890650Crohn Disease
All India Institute of Medical Sciences
Not applicable
168
Kochi, Mumbai, New Delhi, Ludhiana, Chandigarh, Varanasi
2025-03-15
Recruiting
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies
NCT06890637Crohns Disease
All India Institute of Medical Sciences
Not applicable
168
Kochi, Mumbai, New Delhi, Ludhiana, Varanasi, Chandigarh
2025-03-15
Recruiting
Effects of Advanced Trauma Life Supportยฎ on Adult Trauma Patient Outcomes
NCT06321419Wounds and Injuries
Karolinska Institutet
Not applicable
4,320
Dibrugarh, Mumbai, New Delhi, Ludhiana, Dehradun, Kolkata, Chandigarh
2025-02-27
Recruiting
Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess
NCT06847126Liver Abscess
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3
220
Chandigarh
2025-02-25
Recruiting
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
NCT06538077Hepatic Encephalopathy, Decompensated Cirrhosis, Minimal Hepatic Encephalopathy
DrugsLactulose·Rifaximin
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
336
Chandigarh
2025-02-01
Recruiting
Contact Cast Versus Posterior Slab as Offloading Modality for Charcot Neuroarthropathy
NCT06573554Charcot Neuroarthropathy
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
80
Chandigarh
2024-12-11
Recruiting
LIVERAGEโ„ข - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim
Phase 3
1,590
Ahemdabad, Chandigarh, Hyderabad, Afzalgunj, Jaipur, Lucknow, Nagpur, New Delhi, Rohtak
2024-11-12
Not yet open
Prednisolone for 12 Versus 6 Months to Treat Pulmonary Sarcoidosis
NCT06654934Sarcoidosis
DrugPrednisolone
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
100
Chandigarh
2024-11
Recruiting
LIVERAGEโ„ข: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Boehringer Ingelheim
Phase 3
1,800
Ahemdabad, Chandigarh, Hyderabad, Afzalgunj, Jaipur, Lucknow, Mohali, Nagpur, New Delhi
2024-10-14
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787Alzheimer Disease
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Aurangabad, Nagpur, Chandigarh, Ajmer, Hyderabad, Kolkata, Varanasi
2024-09-26
Active, closed
EASi-KIDNEYโ„ข (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824Kidney Disease, Chronic
DrugDapagliflozin
Boehringer Ingelheim
Phase 3
11,000
Bangalore, Bathinda, Bhubaneswar, Bilฤspur, Chandigarh, Chennai, Dwฤrka, Faridabad
2024-08-30
By invitation
Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease
NCT07452744Non Alcholic Fatty Liver Disease
Bioagile Therapeutics Pvt. Ltd.
Not applicable
170
Chandigarh, Panjagutta, Chowk, Mumbai, Delhi, Vasant Kunj
2024-08-13
Recruiting
RCT of Nintedanib in Fibrotic Sarcoidosis
NCT06479603Sarcoidosis, Pulmonary
DrugNintedanib
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
120
Chandigarh
2024-06-30
Recruiting
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
NCT06080789Acute Pancreatitis
Panafina, Inc.
Phase 2
36
Kochi, Vellore, Chandigarh, Delhi, New Delhi
2024-06-28
Recruiting
A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis
NCT06447402Chronic Pulmonary Aspergillosis, CPA, Aspergilloma
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3
196
Chandigarh
2024-06-03
Active, closed
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
NCT06407934Dermatitis Atopic
DrugAmlitelimab
Sanofi
Phase 3
1,541
Ahmedabad, Belagavi, Chandigarh, Faridabad, Kolkata, Nagpur, Pune
2024-05-08
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Bengaluru, Chandigarh, Delhi, Gurgaon, Mangaluru, Nagpur, New Delhi, Thiruvananthapuram
2024-04-16
Not yet open
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
NCT06377397Sepsis, PROM, Preterm (Pregnancy), Early-Onset Neonatal Sepsis, Preterm Premature Rupture of Membrane
Indian Council of Medical Research
Phase 3
1,500
Chandigarh
2024-04-15
Active, closed
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
NCT06073132Generalized Epidermolysis Bullosa Simplex
TWi Biotechnology, Inc.
Phase 2/3
80
Chandigarh
2024-04-04
Not yet open
Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock
NCT06306001Neonatal Sepsis, Shock, Septic
DrugMethylene Blue
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2/3
130
Chandigarh
2024-03-15
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966COPD (Chronic Obstructive Pulmonary Disease)
AstraZeneca
Phase 3
5,000
Ahmedabad, Aligarh, Belagavi, Calicut, Chandigarh, Dehradun, Delhi, Dwฤrka
2024-02-21
Active, closed
MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin
NCT06373523Hepatic Steato-Fibrosis, Non-Alcoholic Fatty Liver Disease
DrugDapagliflozin Tab
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase EARLY_PHASE1
50
Chandigarh
2024-01-15
Recruiting
A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)
NCT06412250Cardiovascular Diseases
Translumina Therapeutics Pvt Ltd.
Observational
2,000
Ahmedabad, Bangalore, Bathinda, Chandigarh, Delhi, Gurugram, Hyderabad, Jabalpur
2024-01-10
Active, closed
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
NCT06141473Multiple Sclerosis
DrugsCholestyramine·Activated Charcoal·Teriflunomide·Frexalimab
Sanofi
Phase 3
1,655
Chandigarh, Hyderabad, Kochi, Nagpur, Nashik, New Delhi, Shimla, Thiruvananthapuram
2023-12-13
Recruiting
POEM-F for Achalasia International Study
NCT06042127Achalasia
Chinese University of Hong Kong
Not applicable
81
Chandigarh, Hyderabad, Mumbai, Pune
2023-12-01
Recruiting
A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
NCT06174922Allergic Bronchopulmonary Aspergillosis
DrugsItraconazole·Prednisolone
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3
300
Chandigarh
2023-12-01
Recruiting
A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
NCT05984147Relapsed Advanced Lymphomas
Aurigene Discovery Technologies Limited
Phase 1
40
Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Srinagar, Belagavi, Kochi
2023-10-19
Recruiting
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
NCT05865002Relapsed Malignant Solid Neoplasm
Aurigene Discovery Technologies Limited
Phase 1
50
Vijayawada, Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Bangalore, Mysore
2023-09-05
Recruiting
Cardiac Dysfunction in Patients with Fatty Liver Disease
NCT06386094NAFLD, Cardiac Disease, Fatty Liver, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Post Graduate Institute of Medical Education and Research, Chandigarh
Observational
150
Chandigarh
2023-07-15
Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT05980949Psychosis Associated With Alzheimer's Disease
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Nagpur, Chandigarh, Ajmer, Hyderabad, Kolkata, Varanasi
2023-07-11
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Hyderabad, Chandigarh, Faridabad, Bengaluru, Trivandrum, Jaipur, Vellore, Lucknow
2023-07-06
Active, closed
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
NCT05966480SLE
DrugEnvudeucitinib
Alumis Inc
Phase 2
408
New Delhi, Ahmedabad, Bangalore, Bengaluru, Chandigarh, Haryฤna, Jaipur, Lucknow
2023-06-26
Active, closed
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
NCT05827016Multiple Myeloma
DrugsIberdomide·Lenalidomide
Bristol-Myers Squibb
Phase 3
1,230
Chandigarh, Bangalore, Kochi, Kolhฤpur, Nagpur, Pune, Bhubaneswar, Kolkata
2023-06-22
Active, closed
A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (ฮฒ-Thal) in India
NCT05891249Anemia
DrugLuspatercept
Bristol-Myers Squibb
Phase 4
85
Ahmedabad, New Delhi, Kolkata, Assam, Bangalore, Chandigarh, Delhi, Hyderabad
2023-06-05
Recruiting
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05850689Major Depressive Disorder
DrugLumateperone
Intra-Cellular Therapies, Inc.
Phase 3
470
Ahmedabad, Ajmer, Bฤrฤmati, Bikaner, Chandigarh, Guwahati, Kolhฤpur, Nagpur
2023-05-02
Active, closed
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guรฉrin (BCG) in Participants With BCG-naรฏve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
NCT05714202Bladder Cancer
DrugsTAR-200·Cetrelimab
Janssen Research & Development, LLC
Phase 3
1,135
Bangalore, Chandigarh, Gurugram, Kolkata, Mumbai, Pune
2023-03-23
Recruiting
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
NCT05696613Primary Membranous Nephropathy
DrugRituximab
Cerium Pharmaceuticals, Inc.
Phase 3
148
Guntur, Nellore, Raipur, Nadiฤd, Belagavi, Nagpur, New Delhi, Chandigarh
2023-03-13
Recruiting
A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
NCT05744921Paroxysmal Nocturnal Hemoglobinuria
DrugsCemdisiran·Pozelimab
Regeneron Pharmaceuticals
Phase 3
202
Kochi, Mumbai, New Delhi, Chandigarh, Jaipur
2023-03-07
Recruiting
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
NCT05252754Post-ERCP Acute Pancreatitis
DrugsRectal Indomethacin·Tacrolimus
Johns Hopkins University
Phase 3
4,874
Hyderabad, Kolkata, Chandigarh
2023-01-18
Active, closed
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
DrugGSK4532990
GlaxoSmithKline
Phase 2
284
Bhubaneswar, Chandigarh, Coimbatore, Guhawati, Mumbai, Nagpur, New Delhi, Secunderabad
2023-01-02
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200Atrial Fibrillation (AF)
DrugAbelacimab
Anthos Therapeutics, Inc.
Phase 3
2,500
Hyderabad, Kochi, Rudrapur, Ahmedabad, Ajmer, Bangalore, Bhubaneswar, Chandigarh
2022-12-27
Active, closed
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
NCT05501886Breast Cancer
DrugsGedatolisib·Alpelisib·Palbociclib·Fulvestrant
Celcuity Inc
Phase 3
701
Jaipur, Bangalore, Chandigarh, Kolkata, Navi Mumbai, Vellore
2022-12-08
Recruiting
Bile Acids Metabolism and Genetic Mutation Profile in the Intrahepatic Cholestasis of Pregnacy in Indian Population
NCT05691036Intrahepatic Cholestasis of Pregnancy, Genetic Mutation, Health Related Quality of Life
Post Graduate Institute of Medical Education and Research, Chandigarh
Observational
150
Chandigarh
2022-12-08
Active, closed
An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
NCT05626387Hypersensitivity Pneumonitis
DrugsMycophenolate Mofetil·Prednisolone
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
144
Chandigarh, Hyderabad, Jaipur, Jodhpur, Lucknow, New Delhi, Rishikesh, Vellore
2022-11-23
Active, closed
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
NCT05567796Obesity
DrugsCagrilintide·Semaglutide
Novo Nordisk A/S
Phase 3
3,400
Surat, Belagavi, Kozhikode, Mumbai, Nagpur, Pune, Delhi, Chandigarh
2022-11-01
Recruiting
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
NCT05929976Acute Lymphoblastic Leukemia, Nutrition Aspect of Cancer, Microtia, Genetic Predisposition
Columbia University
Observational
4,900
Chandigarh
2022-10-26
Active, closed
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
NCT05514054Breast Neoplasms
DrugsImlunestrant·Tamoxifen·Exemestane·Anastrozole
Eli Lilly and Company
Phase 3
8,000
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Chandigarh, Chennai, Hyderabad, Kanpur
2022-10-04
Active, closed
Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials
NCT05492578Dermatitis Atopic
DrugAmlitelimab
Sanofi
Phase 2/3
1,856
Ahmedabad, Belagavi, Chandigarh, Kolkata, Nagpur, Pune
2022-08-22
Recruiting
Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT
NCT06962202Cushing Syndrome
Post Graduate Institute of Medical Education and Research, Chandigarh
Observational
100
Chandigarh
2022-08-15
Recruiting
International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery
NCT05673499Congenital Disorders, Cerebral Desaturation, Neonatal Surgery
Children's Hospital of Philadelphia
Observational
900
Chandigarh, Vellore
2022-08-12
Active, closed
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment
NCT05133531Paroxysmal Nocturnal Hemoglobinuria
DrugsCemdisiran·Pozelimab·Eculizumab·Ravulizumab
Regeneron Pharmaceuticals
Phase 3
202
Kannur, Kochi, Mumbai, New Delhi, Chandigarh, Lucknow, Jaipur
2022-08-01
Active, closed
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
NCT05126277Lupus Nephritis
DrugIanalumab
Novartis Pharmaceuticals
Phase 3
452
Bangalore, Secunderabad, Lucknow, Chandigarh
2022-07-14
Active, closed
A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium
NCT05456425Pterygium
Cloudbreak Therapeutics, LLC
Phase 3
660
Chandigarh, Ahmedabad, Bangalore, Bhubaneswar, Bikaner, Noida
2022-06-30
Recruiting
Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome
NCT05444946Chronic Pulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis
DrugItraconazole
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
104
Chandigarh
2022-06-15
Active, closed
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque, Coronary Artery Disease
Diagram B.V.
Not applicable
1,223
Ahmedabad, Bangalore, Chandigarh
2022-03-16
Active, closed
A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
NCT05224102Diabetic Macular Edema
DrugFaricimab
Genentech, Inc.
Phase 4
218
Hubli, Pune, Ahmedabad, Chennai, Madurai, Kolkata, Chandigarh
2022-02-28
Active, closed
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
NCT05201638Multiple Sclerosis, Relapsing-Remitting
DrugIMU-838
Immunic AG
Phase 3
1,100
Chandigarh, Gurugramam, Kochi, Lucknow, New Delhi, Punjฤbi Bฤgh, Raipur
2022-01-12
Active, closed
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)
NCT05147220Relapsing Multiple Sclerosis
DrugsTeriflunomide·Remibrutinib
Novartis Pharmaceuticals
Phase 3
1,000
Mangalore, Mumbai, Nashik, New Delhi, Chandigarh, Ludhiana, Lucknow, Dehradun
2021-12-16
Active, closed
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
NCT05097287Asthma
DrugDupilumab
Sanofi
Phase 4
1,339
Ahmedabad, Chandigarh, Coimbatore, Jaipur, Jodhpur, Kozhikode, Lucknow, Mangaluru
2021-12-16
Recruiting
European and North Indian Cohort of KaWasaki dIsease
NCT06305611Kawasaki Disease
Meyer Children's Hospital IRCCS
Observational
103
Bangalore, Chandigarh, Chennai, Kochi, Kolkata
2021-07-13
Recruiting
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).
NCT04472845Breast Cancer, Hypofractionation, Radiotherapy Side Effect
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
1,018
Chandigarh
2021-03-30
Active, closed
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
NCT04586023Relapsing Multiple Sclerosis
DrugsFenebrutinib·Teriflunomide
Hoffmann-La Roche
Phase 3
751
Ahmedabad, Mumbai, Pune, New Delhi, Ludhiana, Vadapalani, Chandigarh
2021-03-24
Recruiting
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
NCT04256798Infection, Pneumonia, Surgical Site Infection, Wound Infection
DrugChlorhexidine mouthwash
University of Birmingham
Phase 3
12,942
Visakhapatnam, Srinagar, Chinchpฤda, Madhava Nagar, Patiฤla, Bhubaneswar, Chandigarh, Jodhpur
2020-11-13
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Bangalore, Chandigarh
2020-08-06
Active, closed
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
NCT04232553Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
996
Chandigarh, Surat, Pune, New Delhi, Ludhiana, Jaipur, Chennai
2020-06-22
Active, closed
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
NCT04211337Medullary Thyroid Cancer
DrugsVandetanib·Selpercatinib·Cabozantinib
Loxo Oncology, Inc.
Phase 3
291
Thiruvananthapuram, Nashik, Pune, Kolkata, Chandigarh
2020-02-11
Active, closed
Deflazacort Vs. Prednisolone in Acute-stage ABPA
NCT04227483Allergic Bronchopulmonary Aspergillosis
DrugPrednisolone
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2/3
150
Chandigarh
2020-01-15
Active, closed
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
NCT03650114Relapsing Multiple Sclerosis
Drugs13-valent pneumococcal conjugate vaccine·23-valent pneumococcal polysaccharide vaccine·Ofatumumab
Novartis Pharmaceuticals
Phase 3
1,882
Mangalore, Kochi, Mumbai, Pune, New Delhi, Chandigarh, Hyderabad, Howrah
2018-12-28
Active, closed
Efficacy Of Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial
NCT02473341Alcoholic Hepatitis
Dayanand Medical College and Hospital
Phase 3
174
Ludhiana, Chandigarh, Hyderabad, Jaipur, New Delhi
2017-11-14
Rows per page Showing 1–100 of 104
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-india/city/chandigarh

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in India and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,132 studies in total at the last sync on 27 Sep 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 104 of those studies with a site in Chandigarh.

How many clinical trials are recruiting in Chandigarh?

61 of the 104 studies on this page are recruiting new participants as of the 27 Sep 2026, 03:16 UTC sync. A further 8 have not yet opened recruitment, 34 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chandigarh), 104 studies
PhaseStudiesRecruitingShare
Phase 3472245.2%
Not applicable171516.3%
Observational131312.5%
Phase 412611.5%
Phase 2/3514.8%
Phase 1433.8%
Phase 2413.8%
Phase 1/2101%
Phase EARLY_PHASE1101%

Most active sponsors

Lead sponsors with the most studies (Chandigarh)
Lead sponsorStudiesRecruiting
Post Graduate Institute of Medical Education and Research, Chandigarh2820
Novartis Pharmaceuticals51
Sanofi50
All India Institute of Medical Sciences44
Boehringer Ingelheim43
Eli Lilly and Company42
Aurigene Discovery Technologies Limited22
Bristol-Myers Squibb20
Johnson & Johnson Private Limited21
Karuna Therapeutics, Inc., a Bristol Myers Squibb company22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.